Author

Katie Deering

Observed institutions: University of Southern California, Epi-Q (United States)

OpenAlex ID: A5110158003

Treatment patterns and costs in cutaneous squamous cell carcinoma (CSCC) patients with nodal dissection, chemotherapy, and/or radiation therapy.

2018 · Emily S Ruiz, Chieh-I Chen, et al. · Journal of Clinical Oncology · 9

Shared decision-making tools for patients with hematologic malignancies.

2016 · Thomas William LeBlanc, David Rizzieri, et al. · Journal of Clinical Oncology · 2

Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma

2015 · Thomas W. LeBlanc, Robert C Wolf, et al. · Blood · 1

292: Paricalcitol Treatment in CKD Patients With Secondary Hyperparathyroidism Is Associated With Better Health Outcomes When Compared With No Vitamin D Receptor [VDR] Activator Treatment

2010 · Raimund Sterz, Carla Frye, et al. · American Journal of Kidney Diseases · 1

186: Comparative Efectiveness of Paricalcitol Versus Calcitriol Treatment in Chronic Kidney Disease [CKD] Patients With Secondary Hyperparathyroidism [SHPT]

2010 · Steven Marx, Carla Frye, et al. · American Journal of Kidney Diseases · 1

scFurosemide Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure: The FreEDom-HF Study

2018 · Daniel R. Bensimhon, W. Frank Peacock, et al. · Journal of Cardiac Failure

187: Dialysis Health Outcomes Associated With Pre-Dialysis Use of Paricalcitol Compared With No Vitamin D Receptor (VDR) Activator Treatment

2010 · Steven Marx, Carla Frye, et al. · American Journal of Kidney Diseases

Works count: 8

Citation count: 14

H-index: 2

I10-index: